secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001641172-25-024520
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma exchanges 466,666 warrants for common stock; cancels $17.50 strike warrants
--------------------------------------------------------------------------------

- Entered into Warrant Exchange Agreements on Aug 15, 2025 with certain warrant holders.
- Issued 466,666 shares of common stock in exchange for an equal number of warrants with $17.50 exercise price.
- Warrants were originally issued on April 5, 2024; after exchange, all such warrants are cancelled.
- Exchange was exempt from registration under Section 3(a)(9); no cash consideration involved.
- Shares issued without restrictive legends and are freely tradable under federal securities laws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225024520/0001641172-25-024520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225024520/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-024520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer